18.01.2013 13:50 Uhr, Quelle: Wallstreet online
Novartis receives positive CHMP opinion for Ilaris® to treat patients whose acute gouty arthritis cannot be managed with standard of care
Novartis International AG / Novartis receives positive CHMP opinion for Ilaris® to treat patients whose acute gouty arthritis cannot be managed with standard of care . Processed and transmitted by Thomson Reuters ONE. The issuer is solely …
Weiterlesen bei Wallstreet online
JustMac.info